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Articles
Tropism and innate host responses of a novel avian 
infl uenza A H7N9 virus: an analysis of ex-vivo and in-vitro 
cultures of the human respiratory tract
Michael C W Chan*, Renee W Y Chan*, Louisa L Y Chan*, Chris K P Mok*, Kenrie P Y Hui, Joanne H M Fong, Kin P Tao, Leo L M Poon, 
John M Nicholls, Y Guan, J S Malik Peiris
Summary
Background Since March, 2013, an avian-origin infl uenza A H7N9 virus has caused severe pneumonia in China. The 
aim of this study was to investigate the pathogenesis of this new virus in human beings.
Methods We obtained ex-vivo cultures of the human bronchus, lung, nasopharynx, and tonsil and in-vitro cultures of 
primary human alveolar epithelial cells and peripheral blood monocyte-derived macrophages. We compared virus 
tropism and induction of proinfl ammatory cytokine responses of two human infl uenza A H7N9 virus isolates, 
A/Shanghai/1/2013 and A/Shanghai/2/2013; a  highly pathogenic avian infl uenza H5N1 virus; the highly pathogenic 
avian infl uenza H7N7 virus that infected human beings in the Netherlands in 2003; the 2009 pandemic infl uenza 
H1N1 virus, and a low pathogenic duck H7N9 virus that was genetically diﬀ erent to the human disease causing 
A H7N9 viruses.
Findings Both human H7N9 viruses replicated eﬃ  ciently in human bronchus and lung ex-vivo cultures, whereas 
duck/H7N9 virus failed to replicate in either. Both human A H7N9 viruses infected both ciliated and non-ciliated 
human bronchial epithelial cells and replicated to higher titres than did H5N1 (p<0·0001 to 0·0046) and 
A/Shanghai/1/2013 replicated to higher titres than did H7N7 (p=0·0002–0·01). Both human A H7N9 viruses 
predominantly infected type II alveolar epithelial cells and alveolar macrophages in the human lung and replicated to 
higher titres than did H5N1 (p<0·0001 to 0·0078); A/Shanghai/1/2013 replicated to higher titres than did H1N1 
(p=0·0052–0·05) and H7N7 (p=0·0031–0·0151). Human H7N9 viruses were less potent inducers of proinfl ammatory 
cytokines compared with H5N1 virus.
Interpretation Collectively, the results suggest that the novel H7N9 viruses are better adapted to infect and replicate in 
the human conducting and lower airways than are other avian infl uenza viruses, including H5N1, and pose an 
important pandemic threat.
Funding Area of Excellence Scheme of the University Grants Committee (AoE/M-12/96), Hong Kong Special 
Administrative Region.
Introduction
As of July 7, 2013, 132 laboratory-confi rmed human 
infections with a novel infl uenza A H7N9 virus have been 
reported from ten provinces and municipalities in China 
by the National Health and Family Planning Commission, 
and one additional case has been reported from Taipei 
Centres for Disease Control. There have been 43 deaths so 
far.1,2 The source of human infection appears to be 
poultry.1,3–5 There is so far no evidence of sustained human-
to-human transmission within the community. Genetic 
analysis of these viruses revealed that all eight gene 
segments were of avian origin; six internal gene segments 
were derived from avian infl uenza A H9N2 viruses found 
in poultry in Asia, and the haemagglutinin and 
neuraminidase genes were derived from infl uenza viruses 
circulating in ducks and wild birds, respectively.1
Human infections with other H7 infl uenza viruses 
(H7N2, H7N3, and H7N7) have previously been reported 
in the Netherlands, Canada, USA, and UK6 in association 
with outbreaks in poultry and resulted in conjunctivitis 
with mild upper respiratory symptoms. However, there 
was one fatal case in the Netherlands.6,7
Cytokine dysregulation contributes to the patho-
genesis of human disease caused by highly pathogenic 
avian infl uenza A H5N1 as well as the 1918 pandemic 
H1N1 viruses.8–12 By comparison with seasonal infl uenza 
viruses, some highly pathogenic avian infl uenza H5N1 
viruses induced higher concentrations of pro-
infl ammatory cytokines from human alveolar epithelial 
cells and macrophages.8,9,11–13
We previously used ex-vivo cultures of human 
conjunctiva, nasopharynx, tonsil, bronchus and lung to 
investigate infl uenza14,15 and coronavirus tropism16 and 
used in-vitro cultures of polarised primary human 
alveolar epithelial cells and peripheral blood monocyte 
derived macrophages to compare innate immune 
responses elicited by diﬀ erent infl uenza viruses.8,9,12,13 
In this study, we used these ex-vivo and in-vitro models 
of cultured human tissues and cells to compare the virus 
tropism and host innate immune responses of the novel 
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A H7N9 infl uenza virus with that of the pandemic 
H1N1 virus, highly pathogenic avian infl uenza H5N1 and 
H7N7 viruses, and a low pathogenic duck H7N9 virus.
Methods
Viruses
We used avian infl uenza A H7N9 viruses, A/
Shanghai/1/2013 (Sh1/H7N9) and A/Shanghai/2/2013 
(Sh2/H7N9); a duck H7N9 virus, A/Duck/Jiangxi/ 
3286/ 2009 (duck/H7N9), with a diﬀ erent genetic 
derivation from the two H7N9 viruses as a control; 
a highly pathogenic avian infl uenza H7N7 virus isolated 
from a human patient with fatal disease, 
A/Netherlands/219/2003 (NL/219/H7N7); a highly patho-
genic avian infl uenza H5N1 virus isolated from a fatal 
human infection, A/Hong Kong/483/1997 (H5N1); and a 
2009 pandemic infl uenza virus, A/California/07/2009 
(H1N1pdm). See appendix for further details. All 
experiments were done in a biosafety level 3 facility and 
the use of human tissues had been previously approved 
by the local institutional review board.
Ex-vivo cultures
Fresh bronchus, lung, nasopharynx, and tonsil tissues 
were obtained from patients aged 51 to 65 years 
undergoing elective surgery in Hong Kong and were 
removed as part of clinical care but surplus for routine 
diagnostic requirements as detailed previously.14–16 
Methods of culture, infection, and analysis are detailed 
in the appendix.
In-vitro cultures
The eﬀ ect of desialylation of turkey red blood cells on 
virus haemagglutination was compared (appendix). 
Sialidase DAS181 (NexBio, San Diego, CA, USA), which 
removes both α-2,3-linked and α-2,6-linked sialic acids, 
and Sialidase S (Prozyme, Hayward, CA, USA), which 
removes only α-2,3-linked sialic acids, were compared 
with untreated turkey red blood cells as controls.
To assess innate immune responses, primary human 
pneumocytes and peripheral blood monocyte-derived 
macrophages were derived and used for infection with 
infl uenza virus as previously described.8,9 They were 
Figure 1: Viral replication kinetics of infl uenza A H7N9 virus in ex-vivo cultures of bronchus (A) and lung (B), infected with 106 TCID50/mL of infl uenza viruses at 37°C
Barcharts show the mean virus titre pooled from at least three independent experiments. The horizontal dotted line denotes the limit of detection in the TCID50 assay.; error bars show SEM. Tables show 
statistical signifi cance between virus titres at each timepoint. Red shows that the reference virus titre (listed at the top of the column) is signifi cantly higher than the comparator (viruses listed on the 
left) and black shows that it is signifi cantly lower. TCID50=tissue culture infective dose. ns=non-signifi cant. *p<0·0001.
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infected with infl uenza A viruses at a multiplicity of 
infection of two. The primers and methods used for 
these assays have been reported previously8,9,14,16 and 
detailed methods for quantifi cation of cytokine mRNA 
protein are available in the appendix.
Statistical analysis
Experiments with the human ex-vivo cultures and in-vitro 
cultures of macrophages and pneumocytes were done 
independently with at least three diﬀ erent donors, each in 
duplicate. Results shown in fi gures are the calculated 
mean and SEM. Mock infected tissues served as negative 
controls. The diﬀ erences in log10 transformed viral titres 
and quantitative cytokine and chemokine mRNAs between 
viruses and over time were compared with two-way 
ANOVA followed by a Bonferroni multiple-comparison 
test. Diﬀ erences were deemed signifi cant at p<0·05.
Role of the funding source
The sponsors had no role in study design, data collection, 
analysis, or interpretation, or in the writing of the report. 
JSMP, YG, and JMN had full access to all data in the 
study and had fi nal responsibility for the decision to 
submit for publication.
Results
The human A H7N9 viruses Sh1/H7N9 and Sh2/H7N9 
replicated eﬃ  ciently in ex-vivo cultures of the human 
bronchus and lung (fi gure 1). Sh1/H7N9 and Sh2/
H7N9 viruses replicated similarly in bronchus, but 
Sh1/H7N9 replicated to signifi cantly higher titres than 
Sh2/H7N9 in the lung. Sh1/H7N9 and Sh2/H7N9 virus 
titres in the bronchus and lung were higher than those 
observed with H5N1 virus. Sh1/H7N9 and Sh2/H7N9 
virus titres in bronchus were similar to that observed 
with the H1N1pdm virus, but Sh1/H7N9 replicated to 
higher titres in the lung. Sh1/H7N9 replicated to higher 
titres than NL/219/H7N7 virus, and NL/219/H7N7 
replicated to higher titres than H5N1 virus, in bronchus 
and lung. Limited experimental replicates of ex-vivo 
nasopharyngeal (n=2) and tonsil (n=1) cultures restrict 
statistical analysis, but there was a trend suggesting 
productive replication of Sh1/H7N9 and Sh2/H7N9 in 
nasopharynx (appendix). Duck/H7N9 failed to replicate 
in any of these tissues. Sh2/H7N9 replicated 
in nasopharyngeal tissues at 33°C (appendix).
Immunohistochemistry showed that Sh1/H7N9 and 
Sh2/H7N9 viruses extensively infected bronchial 
epithelium, infecting both ciliated and non-ciliated 
bronchial epithelial cells (fi gure 2C, E), the extent of 
infection being greater than that seen with H5N1 
(fi gure 2G) and other avian viruses (table 1). In the lung, 
Sh1/H7N9 and Sh2/H7N9 infected mainly type II 
pneumocytes (fi gure 3) and alveolar macrophages 
(fi gure 3 and appendix). There was no evidence of 
infection of vascular endothelium in the blood vessels 
of the lung. The duck/H7N9 virus, which diﬀ ers in its 
genetic origin from the viruses causing the current 
human H7N9 outbreak, failed to infect or replicate in 
any of the human tissues tested, with the exception of 
Figure 2: Tissue tropism of infl uenza A H7N9 virus in ex-vivo cultures of bronchus and lung
Formalin-fi xed paraffi  n-embedded sections of bronchus (A, C, E, G) and lung (B, D, F, H) after 24 h infection with 
mock (A, B), Sh1/H7N9 (C, D), Sh2/H7N9 (E, F), and H5N1 (G, H) viruses. Sections were stained with a monoclonal 
antibody against the infl uenza nucleoprotein with positive cells identifi ed as a red-brown colour. Ciliated and 
non-ciliated cells are identifi ed with green and orange arrows, respectively.
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H5N1 +/– +
H1N1/pdm + ++
Duck/H7N9 Sparse –
Sections were stained with a monoclonal antibody to infl uenza nucleoprotein and 
scored in a semiquantitative manner: ++=more than 20% of epithelial cells have 
positive antigen. +=5–20% of epithelial cells have positive antigen. +/–=less than 
5% of epithelial cells have positive antigen. Sparse=only 1–3 positive cells 
identifi ed per section. –=no positive cells identifi ed. 
Table 1: Tissue tropism of infl uenza virus infection of human bronchus 
and lung as assessed by immunohistology
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occasional cells expressing viral antigen seen in the 
bronchial epithelium (table 1).
Treatment of turkey red blood cells with a sialidase that 
specifi cally cleaves the α-2,3-linked sialic acid with 
galactose did not have any eﬀ ect on haemagglutination 
of either Sh1/H7N9 or Sh2/H7N9, whereas it completely 
abolished haemagglutination of H5N1 virus (table 2). 
As a control, DAS181, a sialidase that cleaves both the 
α-2,3 and α-2,6 links of sialic acid, abolished the 
haemagglutination of human and avian infl uenza viruses 
including that of Sh1/H7N9 and Sh2/H7N9.
In human peripheral blood monocyte-derived macro-
phages, infl uenza viral matrix (M) gene expression of 
Sh1/H7N9, Sh2/H7N9, H5N1, and H1N1pdm viruses 
were generally similar at 3, 8, and 24 h post infection, but 
Sh2/H7N9 had signifi cantly higher M-gene copy numbers 
compared with H1N1pdm virus at 8 h after infection and 
H5N1 had signifi cantly higher M-gene expression than 
H1N1pdm at 3 h after infection. As expected, H5N1 
induced signifi cantly more CCL5, CXCL10, tumour 
necrosis factor α (TNFα; at 3, 8, and 24 h post infection), 
CCL2, MX1 (at 8 h post infection), and interferon β (at 3 h 
post infection) mRNA compared with H1N1pdm virus 
(fi gure 4). Sh1/H7N9 and/or Sh2/H7N9 viruses induced 
signifi cantly higher concentrations of interferon β (at 3 h 
post infection), MX1 and CCL5 (at 8 h post infection), and 
CXCL10 (at 8 h and 24 h post infection) mRNA than did 
H1N1pdm virus, but less interferon β and TNFα compared 
with H5N1 at 3 h post infection  (fi gure 4). In parallel, 
H5N1 virus elicited more CCL5 and TNFα protein 
secretion compared with H1N1pdm (fi gure 5). Overall, the 
induction of proinfl ammatory cytokines by Sh1/H7N9 or 
Sh2/H7N9 appeared to be intermediate between those 
induced by H5N1 and H1N1pdm viruses. Sh1/H7N9 and 
Sh2/H7N9 viruses both induced signifi cantly higher 
concentrations of CCL5 and CXCL10 mRNA than did 
H1N1pdm virus, but less interferon β and TNFα compared 
with H5N1 (fi gure 4).
The mRNA expression of genes related to interferon 
and interferon receptor signalling in human peripheral 
blood monocyte-derived macrophages after Sh1/H7N9, 
Sh2/H7N9, H5N1, and H1N1pdm virus infection was 
investigated by cDNA PCR array and expressed as fold-
change over mock infected cells (appendix). Only genes 
that were three or more fold changes overexpressed or 
underexpressed relative to H1N1pdm were noted. 
The interferon stimulated genes MX1, ISG15, IFI35, 
IFI44, IFIH1, and OAS1 were eﬀ ectively upregulated by 
Sh1/H7N9 and Sh2/H7N9 infections (data not shown). 
Expression of IL20RB, IFNAR1, IL20RA, IL22RA2, 
IL2RB, IL9R, and IRF4 were overexpressed by either 
Sh1/H7N9 or Sh2/H7N9 infection compared with 
H1N1pdm infection. IL10RB and IL4R were more 
downregulated by Sh1/H7N9 or Sh2/H7N9 compared 
with H1N1pdm.
In primary human pneumocytes, replication of Sh1/
H7N9 and Sh2/H7N9 viruses (multiplicity of infection 
of two) were similar, as assessed by viral M-gene 
quantitation at 1, 6, and 24 h after infection, whereas 
Sh2/H7N9 had a signifi cantly higher M-gene level 
compared with H5N1 (p=0·05) and H1N1pdm (p=0·0346) 
at 24 h after infection (fi gure 6A). As expected, H5N1 virus 
induced signifi cantly more levels of interferon β, 
interleukin 29, CCL4, CCL5, and CXCL10 mRNA than 
did H1N1pdm virus infection. Sh1/H7N9 and/or Sh2/
H7N9 elicited signifi cantly more interferon β, interleukin 
29, CCL5, and CXCL10 mRNA than did H1N1pdm virus 
infection. However, Sh1/H7N9 and Sh2/H7N9 viruses 
both elicited less interferon β, interleukin 29, and 
CCL5 mRNA than did H5N1 virus (fi gure 6). In virus-
infected cell supernatants, H5N1 virus induced 
signifi cantly more CCL5 protein than did H1N1pdm, 
Sh1/H7N9, and Sh2/H7N9 viruses and more 
CXCL10 protein than did H1N1pdm (fi gure 7).
Discussion
Sh1/H7N9 and Sh2/H7N9 viruses replicated eﬃ  ciently 
in ex-vivo cultures of human bronchus and lung with 
Figure 3: Cellular localisation of infl uenza antigen in human lung tissues infected with infl uenza A H7N9 virus
Serial sections of ex-vivo cultures of human lungs infected with Sh1/H7N9 (A–C) and Sh2/H7N9 viruses (D–F). 
Sections were stained with monoclonal antibodies to infl uenza nucleoprotein (A, D), surfactant protein D (B, E), 
and CD68 (C, F). Green arrows show type II pneumocytes and orange arrows show alveolar macrophages.
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The reciprocal of the haemagglutination titre is denoted. Three independent 
experiments were done with identical results.
Table 2: Eff ect of desialylation on virus haemagglutination of turkey red 
blood cells
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peak viral titres similar to and exceeding that seen with 
H1N1pdm (panel). These fi ndings emphasise the relative 
ease with which H7N9 viruses can infect human beings 
and is compatible with epidemiological observations. 
Peak viral titres in the bronchus and lung were higher 
than those observed with other avian infl uenza viruses 
that have infected humans such as highly pathogenic 
avian infl uenza H5N1 and H7N7. By contrast, the duck/
H7N9 virus, a typically avian virus genetically diﬀ erent 
from Sh1 and Sh2/H7N9 viruses in all eight gene 
segments, failed to replicate eﬃ  ciently in any human 
respiratory tissue.
Figure 4: Cytokine and chemokine mRNA expression profi le in peripheral blood monocyte-derived macrophages infected with mock, Sh1/H7N9, Sh2/H7N9, H5N1, and H1N1pdm viruses
Expression of the infl uenza matrix (M) gene (A), interferon β (B), interleukin 29 (C), MX1 (D), CCL4 (E), CCL2 (F), CCL5 (G), tumour necrosis factor α (TNFα; H), interleukin 8 (I), and CXCL10 (J) at 3, 8, 
and 24 h after infection. Graphs show mean mRNA copies expressed per 105 β-actin copies from three independent experiments; error bars show SEM. MX1=myxovirus resistance 1. CCL=chemokine 
(C-C motif) ligand. CXCL10=chemokine (C-X-C motif) ligand 10. *p<0·05. †p<0·01. ‡p<0·005. 
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Immunohistochemistry of ex-vivo cultures of the 
human bronchus showed Sh1/H7N9 and Sh2/H7N9 
virus infection of both ciliated and non-ciliated epithelial 
cells. H5N1 only led to limited infection in the human 
bronchus with infection restricted to ciliated bronchial 
epithelial cells. In the alveoli, H7N9-infected cells were 
mainly type II pneumocytes and macrophages. Type II 
alveolar epithelial cells are important in producing 
surfactant proteins A and D and are crucial in 
reconstituting damaged type I alveolar epithelium. Loss 
of type II pneumocytes would lead to impairment of the 
repair processes after alveolar damage. The tropism of 
Sh1/H7N9 and Sh2/H7N9 infection in the alveoli is 
similar to that seen with H5N1 infection,17 but the extent 
of infection of the bronchus and lung is signifi cantly 
greater than that seen with H5N1. Although individual 
genetic and environmental variability might result in 
diverse phenotypes, that three separate donors yielded 
very similar trends is interesting (data not shown). 
Future work needs to address whether genetic (eg, 
IFITM3) or other host factors play a part in susceptibility 
to infection of ex-vivo human respiratory cultures.
Sh1/H7N9 and Sh2/H7N9 viruses diﬀ er in aminoacid 
residues Gln226Leu, Ser138Ala, and Gly186Val (H7/H3 
numbering) in haemagglutinin, which are expected to 
enhance binding of Sh2/H7N9 to α-2,6 glycans found in 
the human upper airways.4 However, Sh1/H7N9 and 
Sh2/H7N9 infect human bronchus with similar 
eﬃ  ciency. A sialidase specifi c for cleaving the α-2,3 
glycosidic abolished the haemagglutination of turkey 
red blood cells by H5N1 virus, but did not aﬀ ect 
haemagglutination by Sh1/H7N9 or Sh2/H7N9 viruses 
suggesting that both Sh1/H7N9 and Sh2/H7N9 
predominantly bind α-2,6 glycans, irrespective of 
diﬀ erences in aminoacid residues Gln226Leu, 
Ser138Ala, and Gly186Val of haemagglutinin. Both Sh1/
H7N9 and Sh2/H7N9 have lost a glycosylation site 
(Thy160Ala) in the 150-loop of haemagglutinin that is 
known to result in increased aﬃ  nity for binding α-2,6-
linked glycans in H5N1 viruses.4 By contrast, others 
have reported that a recombinant Sh2/H7N9-like virus 
haemagglutinin bound poorly to human trachea and a 
Gly228Ser aminoacid change was needed to confer 
improved binding to the human upper airways.18 
Recombinant viral haemagglutinin might not accurately 
refl ect haemagglutinin binding of native virions where 
multivalent trimeric haemagglutinin is present together 
with neuraminidase and fails to take into account any 
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Figure 5: Cytokine and chemokine protein expression in cell culture supernatants of peripheral blood monocyte-derived macrophages infected with mock, 
Sh1/H7N9, Sh2/H7N9, H5N1, and H1N1pdm viruses
Expression of CCL2 (A), CCL5 (B) tumour necrosis factor α (TNFα; C), and CXCL10 (D) at 24 h post infection by ELISA (R&D Systems, Minneapolis, MN, USA). Graphs 
show mean protein from three independent experiments; error bars show SEM. CCL=chemokine (C-C motif) ligand. CXCL10=chemokine (C-X-C motif) ligand 10. 
*p<0·005. †p<0·01. 
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role that the virus neuraminidase (via the catalytic site 
or the second neuraminidase binding site) might have 
in virus binding. On the other hand, others have used 
labelled H7N9 to defi ne virus binding to human 
respiratory tract tissues, indicating that both Sh1/H7N9 
and Sh2/H7N9-like viruses bind very eﬃ  ciently to the 
human bronchus (T Kuiken, personal communication).
Recent mass spectrometric data have shown that the 
bronchus contains sialylated α-2,3 glycans,19 explaining its 
infection by avian viruses (H5N1 and H7N7) whose glycan 
array profi les indicate predominant α-2,3 receptor 
binding. Receptor binding and structural analysis of 
Sh2/H7N9-like virus haemagglutinin shows eﬃ  cient 
binding of both α-2,3 and α-2,6 receptors.20 The functional 
changes in receptor binding and PB2 Glu627Lys are some 
of the key functional changes identifi ed by Herfst and 
colleagues21 in 2012 to be important in adapting an avian 
H5N1 virus towards transmission in mammals. Since 
A/Hong Kong/483/97 (H5N1) virus also has lysine at 
position 627 in PB2, the eﬃ  cient replication of 
H7N9 viruses in human ex-vivo cultures of the bronchus 
is unlikely to be explained solely on this basis.
Autopsy data for the lung would provide useful data to 
understand the pathogenesis of human A H7N9 disease. 
However, autopsy data usually only provide information 
about lung pathology at late stages of the illness and thus 
fail to provide insights into virus tropism in the early 
stages of infection. Thus data from experimental 
infection of ex-vivo cultures of the respiratory tract 
provide unique insights into virus tropism and 
pathogenesis. Reported patients with H7N9 disease have 
been older than those with human infections with avian 
H5N1 or H9N2 viruses, and severe disease appears to be 
more common with increasing age.3 The biological basis 
for this unusual epidemiological pattern needs to be 
understood because it diﬀ ers from that seen in 
individuals infected with H5N1. Whether milder cases in 
young people are unrecognised, thereby skewing the 
case–fatality ratio as well as the age distribution, is 
unclear. Paediatric lung and bronchial tissues diﬀ er from 
adult tissues in the balance of sialylated α-2,3 and α-2,6 
glycans,19 and this factor might contribute to the increased 
disease severity with increasing age. However, using 
similar techniques we found that Sh1/H7N9 and Sh2/
H7N9 viruses eﬃ  ciently infected ex-vivo lung from a 
1-year-old child (data not shown). Chronic lung disease 
increases numbers of type II pneumocytes (the target 
cells for infl uenza viruses) and might contribute to an 
increased disease severity compared with younger, 
healthier individuals.22
Dysregulation of proinfl ammatory innate immune 
responses by highly pathogenic avian infl uenza H5N1 
virus contributed to the unusual severity of human 
H5N1 disease and investigation of whether Sh1 or 
Sh2/H7N9 virus infections lead to exaggerated pro-
infl ammatory innate immune responses was relevant. 
Since ex-vivo cultures are heterogeneous in cell type and 
susceptibility to virus and the infecting dose cannot be 
precisely controlled, we chose to compare innate immune 
responses to H7N9 infection with that of highly pathogenic 
61 24
Hours post infection
61 24
Hours post infection
61 24
Hours post infection
M
 g
en
e/
10
⁵ β
-a
ct
in
10⁶
10⁴
10²
10⁰
A
CC
L4
/1
0⁵
 β
-a
ct
in
150
100
50
0
D
In
te
rfe
ro
n 
β/
10
⁵ β
-a
ct
in
150
100
50
0
B
In
te
rle
uk
in
 2
9/
10
⁵ β
-a
ct
in
2000
1000
500
0
C
1500
CX
CL
10
/1
0⁵
 β
-a
ct
in
1000
500
0
1500
CC
L5
/1
0⁵
 β
-a
ct
in
2000
1000
500
0
E
1500
F
†
*
*
**
‡
†
*
†
‡ ‡ ‡
*
†
*
‡
‡
*
‡
†
‡
‡
Mock
Sh1/H7N9
Sh2/H7N9
H5N1
H1N1pdm
Figure 6: Cytokine and chemokine mRNA expression profi le in human pneumocytes infected with mock, Sh1/H7N9, Sh2/H7N9, H5N1, and H1N1pdm viruses
Expression of infl uenza matrix (M) gene (A), interferon β (B), interleukin 29 (C), CCL4 (D), CCL5 (E), and CXCL10 (F) at 1, 6, and 24 h after infection. Graphs show mean mRNA copies expressed per 
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avian infl uenza H5N1 and H1N1pdm viruses in well 
defi ned primary human macrophages and alveolar 
epithelial cells. By comparison with H5N1 virus (a high 
cytokine-inducing virus) and H1N1pdm virus (a low 
cytokine-inducing virus), Sh1/H7N9 and Sh2/H7N9 
appear to have an intermediate phenotype in their intrinsic 
capacity to induce proinfl ammatory cytokines such as 
CCL5 and TNFα. The expression of interferon stimulated 
genes (eg, MX1, ISG15) did not appear to be impaired. 
Lungs and serum of mice experimentally infected with 
Sh2/H7N9 also had lower concentrations of 
proinfl ammatory chemokines and cytokines compared 
with those of H5N1-infected mice.23 In a patient with mild 
disease and one with severe disease in whom cytokine 
concentrations were studied, there was no diﬀ erence in 
proinfl ammatory cytokines in serum. However, the patient 
who died had high serum concentrations of the anti-
infl ammatory cytokine serum interleukin 10.5 Raised 
plasma or lung cytokine concentration might be secondary 
to more severe pathology in severely ill patients,24 or 
secondary to increased replication competence of a virus 
rather than being the intrinsic cause of such pathology. 
Therefore, the experiments we have described in which 
similar virus infecting doses of diﬀ erent viruses are 
compared for their capacity for cytokine induction provides 
important data to defi ne the intrinsic viral capacity for 
proinfl ammatory cytokine induction, which might be of 
relevance for pathogenesis and therapy. From our fi ndings, 
Sh2/H7N9-like viruses appear to be intrinsically more 
potent inducers of the proinfl ammatory cytokine responses 
than are H1N1pdm viruses, but less so than H5N1 viruses. 
Thus, proinfl ammatory cytokine responses might 
contribute in part to the severity of human H7N9 disease, 
but the unusual tissue tropism of this virus for human 
bronchus and lung and attendant direct viral cytopathology 
probably has a more important role in pathogenesis, as 
was seen with the novel Middle East respiratory syndrome 
coronavirus.16
Our fi ndings suggest that Sh2/H7N9-like avian viruses 
are exceptionally fi t to infect mammalian species 
including human beings. Ferrets experimentally infected 
with Sh2/H7N9 showed eﬃ  cient virus replication in the 
respiratory tract with ineﬃ  cient ferret-to-ferret trans-
mission by airborne droplets.25 Although no sustained 
human-to-human transmission has been noted to date, 
the eﬃ  cient replication of these H7N9 viruses in the 
human respiratory tract and the detection (albeit 
ineﬃ  cient) of ferret-to-ferret transmission by the 
airborne route by these viruses without previous 
adaptation increases the pandemic concern associated 
with these viruses.
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Panel: Research in context
Systematic review
We searched PubMed on May 31, 2013 with the terms 
“H7N9” and “virus tropism” or “innate immunity” or 
“autopsy” and found none pertaining to the novel infl uenza 
A H7N9 virus. No date or language restrictions were applied. 
There were papers pertaining to other H7 infl uenza viruses 
and one pertaining to the pathogenesis of this virus. Those 
relevant to the data presented in this Article have been cited 
in the bibliography. An understanding of the tropism of a 
novel infl uenza virus for the human respiratory tract is 
important to assess the zoonotic and pandemic risk posed by 
these viruses.
Interpretation
The novel avian origin human infl uenza A H7N9 viruses 
replicated more effi  ciently than did other avian infl uenza 
viruses and similarly to the pandemic 2009 H1N1 virus in 
ex-vivo cultures of the human respiratory tract. Collectively, 
the results suggest that the novel H7N9 viruses pose a 
signifi cant zoonotic and pandemic threat. 
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Supplementary Figure 1 
Viral replication kinetics of influenza H7N9 viruses in ex vivo cultures of 
nasopharynx (A) and tonsil (B), infected with 106 TCID50/ml of influenza viruses at 
37°C or 33°C, as indicated. The bar chart shows the mean and the SE of mean of the 
virus titer. Significance is denoted as **p < 0.01.   
 
Supplementary Figure 2 
Double labeling of lung tissue sections infected with influenza Sh1/H7N9 and 
Sh2/H7N9 viruses and stained with the antibody to CD68 (macrophage) and HB65 
(influenza NP), showing the co-localization of influenza positive cells in alveolar 
macrophages (yellow arrow). Magnification × 400.  
 
Supplementary Figure 3 
Fold regulation of selected genes related to IFN and IFN receptor signaling in human 
peripheral blood monocyte derived macrophages following influenza Sh1/H7N9, 
Sh2/H7N9, H5N1 and H1N1pdm virus infection, compared with mock infected 
cells are shown.  mRNA was isolated in triplicate from cells infected at an MOI of 
two, collected at 24 hpi and examined by real-time RT-PCR array analysis. A total of 
84 genes were examined. Only genes which exhibited greater than three-fold change 
in expression over (A) or under (B) that expressed by H1N1pdm-infected cells are 
shown. Asterisk signifies genes where statistical significance is achieved (p < 0.05) 
when compared to H1N1pdm. The graph shows the mean fold change from three 
independent experiments.
 ͷ
Material and methods 
 
Viruses 
The viruses used in this study were the avian-origin influenza H7N9 viruses  
A/Shanghai/1/2013 (Sh1/H7N9) and A/Shanghai/2/2013 (Sh2/H7N9); 
A/Duck/Jiangxi/3286/2009 (duck/H7N9) which is a duck virus that is of different genetic 
derivation from the human H7N9 viruses currently causing zoonotic infection; a highly 
pathogenic avian influenza (HPAI) avian influenza H7N7 virus A/Netherland/219/2003 
(NL/219/H7N7) isolated from a fatal human infection; HPAI H5N1 virus isolated from a fatal 
human infection A/Hong Kong/483/1997 (H5N1); and the 2009 pandemic influenza virus 
A/California/07/2009 (H1N1pdm). The viruses were passaged in Madin-Darby canine kidney 
(MDCK) cells and virus stock was aliquoted and titrated to determine tissue culture infection 
dose 50% (TCID50) in MDCK cells. The experiments were carried out in a Bio-safety level 3 
(BSL-3) facility in the Centre of Influenza Research, School of Public Health, The University 
of Hong Kong.   
 
In vitro and ex vivo cell cultures 
Primary human in vitro cultures of pneumocytes, peripheral blood monocyte derived 
macrophages and ex vivo cultures of human respiratory tract were derived and cultured as 
previously described 1-5 with modifications.  
 
Human alveolar epithelial cells isolation 
Primary human pneumocytes were isolated using human non-malignant lung tissue obtained 
from patients undergoing lung resection in the Division of Cardiothoracic Surgery, 
Department of Surgery, Queen Mary Hospital, Hong Kong SAR, under a study approved by 
the Institutional Review Board of the University of Hong Kong and Hospital Authority Hong 
Kong West Cluster. After removing visible bronchi, the lung tissue was minced into pieces of 
> 0.5 mm thickness using a tissue chopper and washed with balanced salt solution (BSS) 
containing Hanks' balanced salt solution (Gibco, USA) with 0.7 mM sodium bicarbonate 
(Gibco, USA) at pH 7.4 three times to partially remove macrophages and blood cells. The 
tissue was digested using a combination of 0.5% trypsin (Gibco, USA) and 4 U/ml elastase 
(Worthington Biochemical Corporation, USA) for 40 min at 37°C in a shaking water-bath. 
The digestion was stopped by adding DMEM/F12 medium (Gibco, USA) with 40% FBS in 
and DNase I (350 U/ml) (Sigma, USA). Cell clumps were dispersed by repeatedly pipetting 
 ͸
the cell suspension for 10 min. A disposable cell strainer (gauze size of 50 Pm) (BD 
Bioscience, USA) was used to separate large undigested tissue fragments. The single cell 
suspension in the flow-through was centrifuged and resuspended in a 1:1 mixture of 
DMEM/F12 medium and small airway basal medium (SABM) (Lonza, USA) supplemented 
with 0.5 ng/ml epidermal growth factor (hEGF), 500 ng/ml epinephrine, 10 ȝg/ml transferrin, 
5 ȝg/ml insulin, 0.1 ng/ml retinoic acid, 6.5 ng/ml triiodothyronine, 0.5 ȝg/ml hydrocortisone, 
30 ȝg/ml bovine pituitary extract and 0.5 mg/ml BSA together with 5% FBS and 350 U/ml 
DNase I. The cell suspension was plated on a tissue culture grade plastic flask (Corning, USA) 
and incubated in a 37qC water-jacketed incubator with 5% CO2 supply for 90 min. The non-
adherent cells were layered on a discontinuous cold Percoll density gradient (densities 1.089 
and 1.040 g/ml) and centrifuged at 25×g for 20 min without brake. The cell layer at the 
interface of the two gradients was collected and washed four times with BSS to remove the 
Percoll. The cell suspension was incubated with magnetic beads coated with anti-CD14 
antibodies at room temperature (RT) for 20 min under constant mixing. After the removal of 
the beads using a magnet (MACS CD14 MicroBeads), cell viability was assessed by trypan-
blue exclusion. The purified pneumocyte suspension was resuspended in small airway growth 
medium (Lonza, USA) supplemented with 1% FBS, 100 U/ml penicillin and 100 ȝg/ml 
streptomycin and plated at a cell density of 3u105 cells/cm2. The cells were maintained in a 
humidified atmosphere (5% CO2, 37°C) under liquid-covered conditions and growth medium 
was changed daily starting from 60 h after plating the cells. When the cell layer approached 
75% confluence, the pneumocytes were trypsinised and detached into Hank’s buffered saline 
solution  
 
Isolation and culture of primary human peripheral blood monocyte derived 
macrophages 
Peripheral blood leucocytes were separated from buffy coats of healthy blood donors from 
the Hong Kong Red Cross Blood Transfusion Service by centrifugation on a Ficoll-Paque 
density gradient and monocytes were purified by adherence on plastic petri dishes as 
described previously3. Monocytes were seeded onto tissue culture plates in RPMI 1640 
medium supplemented with 5% heat-inactivated autologous plasma. The purity of the 
monocyte preparations was confirmed by immunostaining for the surface receptor CD14 (BD 
Biosciences, USA). Cells were allowed to differentiate for 14 days in vitro before use. 
 ͹
Culture medium was changed to macrophage serum free medium SFM (Gibco, USA) a week 
before infection. 
 
Ex vivo culture of human respiratory tract 
Fresh biopsies of human bronchus, lung parenchyma, tonsil and/or nasopharynx obtained 
from patients undergoing surgical resection of lung tissue at Department of Cardiothoracic 
Surgery or Ear Nose & Throat surgery, The University of Hong Kong, Queen Mary Hospital 
as part of clinical care but surplus for routine diagnostic requirements were used in this study. 
All the studies were approved by the Institutional Review Board of the University of Hong 
Kong and Hospital Authority Hong Kong West Cluster. For the ex vivo cultures of human 
lung and bronchus, the age range of the donors from Hong Kong providing bronchus and 
lung tissues was from age of 51 to 65 years. The lung tissue fragments were placed into 
culture medium (F-12K nutrient mixture with L-glutamine, and antibiotics) in 24-well tissue 
culture plates incubated at 37oC. The tonsil, nasopharyngeal and bronchial biopsies or tissue 
fragments were placed into culture medium (F-12K nutrient mixture with L-glutamine, and 
antibiotics) incubated at 37oC or 33oC as indicated. The tonsil, nasopharyngeal and bronchial 
tissues were incubated with a sterile surgical pathology sponge to establish an air-liquid 
interface condition in 24-well culture plates.  
 
Infection of human pneumocytes and peripheral blood monocyte derived macrophages 
in vitro 
Human pneumocytes and macrophages cultures were infected with influenza A viruses at a 
MOI of two for the analysis of cytokine and chemokine expression. MEM medium (Gibco, 
USA) with 100 U/ml penicillin and 100 Pg/ml streptomycin was used as inoculum in the 
mock infected cells. The cell cultures were incubated with the virus inoculum for one hour in 
a water-jacketed 37°C incubator with 5% CO2. The cells were rinsed three times with warm 
PBS and replenished with the appropriate growth medium. The infected cells were harvested 
for mRNA collection at 3, 8 and 24 hpi for macrophages and 1, 6 and 24 hpi for pneumocytes. 
Influenza viral matrix (M) gene was quantified using qPCR as described1, 2.  
 
Influenza virus infection of ex vivo cultures 
Fragments of normal human bronchus, lung parenchyma, tonsil or nasopharynx were cut into 
multiple 2-3 mm fragments and were infected with the respective influenza A viruses within 
 ͺ
two hours of collection. The viruses were used at a titer of 1u106 TCID50/ml (a similar titer to 
that used by Shinya et al 6) for infecting the ex vivo cultures. The biopsy or tissue fragments 
were incubated at 37oC on the cell culture plates or culture sponge to establish an air-liquid 
interface for 24 hour for lung and bronchus tissue respectively, at which time the tissues were 
fixed in 10% neutral buffered formalin and processed for paraffin embedding and 
immunohistochemistry (see below) using a mouse anti-influenza nucleoprotein antibody 
(HB65, EVL Laboratories, The Netherlands). To determine productive viral replication in 
bronchus, lung parenchyma, tonsil or nasopharynx, tissue fragments were cultured in 1 ml of 
F12K with 100 units/ml penicillin and 100 µg/ml streptomycin at 33oC, and infected with 
influenza A viruses at a titer of 1 x 106 TCID50/ml. After one hour, infection the unattached 
virus was removed by washing and viral yield in the cell free supernatant was assessed at 1, 
24, 48 and 72 hpi by titration in quadruplicate in MDCK cells. The increasing virus titers in 
the cull supernatants provided evidence of productive virus replication.  
 
Viral titration by TCID50 assay 
A confluent 96-well tissue culture plate of MDCK cells was prepared one day before the 
virus titration (TCID50) assay. Cells were washed once with PBS and replenished with serum-
free MEM medium supplemented with 100 units/ml penicillin and 100 Pg/ml streptomycin 
and 2 Pg/ml of TPCK (tosylsulfonyl phenylalanylchloromethyl ketone) treated trypsin. Serial 
dilutions of virus supernatant, from 0.5 log to 7 log, were performed before adding the virus 
dilutions onto the plates in quadruplicate. The plates were observed for cytopathic effect daily. 
The end-point of viral dilution leading to CPE in 50% of inoculated wells was estimated 
using the Karber method 7. 
 
Haemagglutination (HA) of turkey red blood cells and the effect of desialylation  
Turkey red blood cells (TRBC) were purchased from Lampire, USA. They were washed and  
reconstituted to 1% in cold PBS. Desialylation was carried out by incubating the cells with 
either 500U/ml of sialidase, DAS181 (NexBio,USA) or 20mU/ml of Sialidase S (Prozyme, 
USA) at 37 oC for 2h. The treated 1% TRBC were then washed with cold PBS by 
centrifugation at 2000 rpm until the supernatant was clear and then resuspended in PBS to 
0.5% for haemagglutination assay. 
 
 ͻ
Serial two-fold dilutions of virus using PBS were performed in a U-bottom 96 well plate in 
triplicate. PBS served as negative control of the HA assay. Equal volumes of control 
(untreated) or sialidase pre-treated 0.5% TRBC were added to the diluted viruses. After 20 
min of incubation at room temperature, the plates were read. A red button formed in the 
negative control. HA titer of each treatment was recorded as a reciprocal of the highest titre 
that gave haemagglutination.  
 
Immunohistochemical staining  
Immunohistochemical staining of the respiratory tract tissue was carried out for the influenza 
nucleoprotein as follows. The tissue sections with incubated with 0.05% Pronase (Roche, 
Switzerland) in 0.1% CaCl2 pH 7.8 at 37 qC for 2 min, blocked with 3% H2O2 in TBS for 10 
min followed by treatment with an avidin/biotin blocking kit (Vector Lab, USA). After 
blocking with 10% normal rabbit serum for 10 min at RT, the sections were incubated with 
1/100 (15 Pg/ml) HB65 (EVL anti-influenza NP, subtype A) antibody for 1 h at room 
temperature (RT) followed by biotinylated rabbit anti-mouse (Dako Cytomation, USA) 
diluted 1/100 for 30 min at RT. After incubation with strep-ABC complex (Dako Cytomation, 
USA) diluted 1/100 for 30 min at RT, the sections were developed with 0.5 mg/ml DAB 
(Sigma) in 0.02% H2O2 for 20 min and then microwaved in 10 mM citrate buffer pH 6.0 for 
20 min to expose the second antigen. The sections were then incubated with FITC-conjugated 
CD68 (Dako Cytomation, USA) at 1/10 for 1 hours at RT and then counterstained with 1.5 
PM propidium iodide (Sigma, USA) for 4 min and then mounted with fluorescent mounting 
medium (Dako Cytomation, USA). Antibodies to CD68 for macrophages and surfactant 
protein D (Abcam, UK) for type II pneumocytes were used for consecutive slide labeling.  
 
Quantification of cytokine and chemokine mRNA profile by RT-qPCR  
Primary human pneumocytes and peripheral blood-derived macrophages were infected with 
influenza A viruses at a multiplicity of infection (MOI) of two. mRNA from infected cells 
was extracted using RNeasy Mini kit (Qiagen, Germany) and treated with DNase. cDNA was 
synthesized with Oligo-dT primers and Superscript III reverse transcriptase (Invitrogen, USA) 
and quantified by real-time PCR amplification using ABI 7500 PCR system (Applied 
Biosystem, USA). The gene expression profiles of the influenza viral matrix 1 gene; 
cytokines TNF-Į, interleukin (IL)-29, interferon ȕ (IFNȕ); chemokines CXCL10, RANTES, 
MCP-1, MIP-1ȕ and interferon stimulated genes Mx1 were quantified and normalized using 
 ͳͲ
the housekeeping gene ȕ-actin mRNA at the time points stated above. The primers and 
methods used for these assays have been reported previously1, 4, 8. RT2 Profiler PCR array 
(PAHS-064Z, SABioscience, Qiagen, Germany) is used for the detection of mRNA level of 
human interferons and receptors. Master-mix composed of Power SYBR Green PCR Master 
Mix (Applied Biosystem, USA) and cDNA prepared from 500 ng total RNA extracted from 
macrophages at 24hpi was subjected to real-time PCR amplification for 40 cycles using ABI 
7500 PCR system (Applied Biosystem, USA). Gene expression and statistical analysis were 
calculated according to the manufacturer’s instructions.  
 
Quantification of cytokine and chemokine proteins in infected culture supernatants by 
ELISA 
Protein expression levels of CXCL10, IL-8, MCP-1, MIP-1ȕ, TNFĮ, RANTES, in the virus-
free cell supernatant collected from influenza viruses infected alveolar epithelial cells and 
macrophages were quantitatively determined by ELISA assay as recommended by the 
manufacturer (R&D Systems, USA). In brief, cells infected with different strains of influenza 
viruses and cell culture supernatants were collected at 24 hpi. 100 µl of supernatant from each 
sample was processed according to the manufacturer’s protocol.  
 
Statistical analysis 
Experiments with the human ex vivo cultures of bronchus and lung and in vitro cultures of 
macrophages and pneumocytes were performed independently with at least three different 
donors, each in duplicate. Results shown in Figures are the calculated mean and standard 
error of mean. Mock infected tissues served as negative controls. The differences in log10 
transformed viral titres, quantitative cytokine and chemokine mRNAs between viruses and 
over time was compared using two-way analysis of variance followed by a Bonferroni 
multiple-comparison test. Differences were considered significant at a p < 0.05.  
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